Acurian Doubles Enrollment Rates of US Sites to Rescue a Global Diabetes Study

Endocrinology

Diabetes/Obesity / Type 2 Diabetes

This was a critical phase III trial designed to be the most important study in this sponsor’s upcoming FDA submission for an innovative new Type 2 diabetes treatment.

Read More »